Global Rare Disease Genetic Testing Market Research Report 2025(Status and Outlook)
Rare disease genetic testing involves the use of molecular diagnostic techniques?such as next-generation sequencing (NGS), whole exome sequencing (WES), whole genome sequencing (WGS), and targeted gene panels?to identify genetic variants responsible for rare, often undiagnosed or misdiagnosed, medical conditions. These tests are designed to detect pathogenic mutations, aiding in accurate diagnosis, prognosis, family planning, and, in some cases, guiding targeted therapeutic interventions. The market encompasses a range of stakeholders, including clinical laboratories, diagnostic companies, academic research institutions, and healthcare providers, and is characterized by a high degree of specialization due to the complexity and heterogeneity of rare genetic disorders.
The global Rare Disease Genetic Testing market size was estimated at USD 102.5 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.75% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Rare Disease Genetic Testing market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Rare Disease Genetic Testing market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Rare Disease Genetic Testing market.
Global Rare Disease Genetic Testing Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Quest Diagnostics
Centogene
Invitae Corporation
3billion
Arup Laboratories
Eurofins Scientific
Strand Life Sciences
Ambry Genetics
Perkin Elmer
Macrogen
Baylor Genetics
Color Genomics
Preventiongenetics
Progenity
Coopersurgical
Fulgent Genetics
Myriad Genetics
LabCorp
Opko Health
Market Segmentation (by Type)
Next-Generation Sequencing (NGS)
Array Technology
PCR-based Testing
Fluorescence in Situ Hybridization (FISH)
Sanger Sequencing
Karyotyping
Others
Market Segmentation (by Application)
Research Laboratories and CROs
Diagnostic Laboratories
Hospitals and Clinics
Others
Geographic Segmentation
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Rare Disease Genetic Testing Market
Overview of the regional outlook of the Rare Disease Genetic Testing Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Rare Disease Genetic Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Rare Disease Genetic Testing, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Rare Disease Genetic Testing market size was estimated at USD 102.5 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.75% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Rare Disease Genetic Testing market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Rare Disease Genetic Testing market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Rare Disease Genetic Testing market.
Global Rare Disease Genetic Testing Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Quest Diagnostics
Centogene
Invitae Corporation
3billion
Arup Laboratories
Eurofins Scientific
Strand Life Sciences
Ambry Genetics
Perkin Elmer
Macrogen
Baylor Genetics
Color Genomics
Preventiongenetics
Progenity
Coopersurgical
Fulgent Genetics
Myriad Genetics
LabCorp
Opko Health
Market Segmentation (by Type)
Next-Generation Sequencing (NGS)
Array Technology
PCR-based Testing
Fluorescence in Situ Hybridization (FISH)
Sanger Sequencing
Karyotyping
Others
Market Segmentation (by Application)
Research Laboratories and CROs
Diagnostic Laboratories
Hospitals and Clinics
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Rare Disease Genetic Testing Market
Overview of the regional outlook of the Rare Disease Genetic Testing Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Rare Disease Genetic Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Rare Disease Genetic Testing, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Rare Disease Genetic Testing
1.2 Key Market Segments
1.2.1 Rare Disease Genetic Testing Segment by Type
1.2.2 Rare Disease Genetic Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 RARE DISEASE GENETIC TESTING MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 RARE DISEASE GENETIC TESTING MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Rare Disease Genetic Testing Product Life Cycle
3.3 Global Rare Disease Genetic Testing Revenue Market Share by Company (2020-2025)
3.4 Rare Disease Genetic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Rare Disease Genetic Testing Company Headquarters, Area Served, Product Type
3.6 Rare Disease Genetic Testing Market Competitive Situation and Trends
3.6.1 Rare Disease Genetic Testing Market Concentration Rate
3.6.2 Global 5 and 10 Largest Rare Disease Genetic Testing Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 RARE DISEASE GENETIC TESTING VALUE CHAIN ANALYSIS
4.1 Rare Disease Genetic Testing Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF RARE DISEASE GENETIC TESTING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Rare Disease Genetic Testing Market Porter's Five Forces Analysis
6 RARE DISEASE GENETIC TESTING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Rare Disease Genetic Testing Market Size Market Share by Type (2020-2025)
6.3 Global Rare Disease Genetic Testing Market Size Growth Rate by Type (2021-2025)
7 RARE DISEASE GENETIC TESTING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Rare Disease Genetic Testing Market Size (M USD) by Application (2020-2025)
7.3 Global Rare Disease Genetic Testing Sales Growth Rate by Application (2020-2025)
8 RARE DISEASE GENETIC TESTING MARKET SEGMENTATION BY REGION
8.1 Global Rare Disease Genetic Testing Market Size by Region
8.1.1 Global Rare Disease Genetic Testing Market Size by Region
8.1.2 Global Rare Disease Genetic Testing Market Size Market Share by Region
8.2 North America
8.2.1 North America Rare Disease Genetic Testing Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Rare Disease Genetic Testing Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Spain
8.4 Asia Pacific
8.4.1 Asia Pacific Rare Disease Genetic Testing Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Rare Disease Genetic Testing Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Rare Disease Genetic Testing Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Quest Diagnostics
9.1.1 Quest Diagnostics Basic Information
9.1.2 Quest Diagnostics Rare Disease Genetic Testing Product Overview
9.1.3 Quest Diagnostics Rare Disease Genetic Testing Product Market Performance
9.1.4 Quest Diagnostics SWOT Analysis
9.1.5 Quest Diagnostics Business Overview
9.1.6 Quest Diagnostics Recent Developments
9.2 Centogene
9.2.1 Centogene Basic Information
9.2.2 Centogene Rare Disease Genetic Testing Product Overview
9.2.3 Centogene Rare Disease Genetic Testing Product Market Performance
9.2.4 Centogene SWOT Analysis
9.2.5 Centogene Business Overview
9.2.6 Centogene Recent Developments
9.3 Invitae Corporation
9.3.1 Invitae Corporation Basic Information
9.3.2 Invitae Corporation Rare Disease Genetic Testing Product Overview
9.3.3 Invitae Corporation Rare Disease Genetic Testing Product Market Performance
9.3.4 Invitae Corporation SWOT Analysis
9.3.5 Invitae Corporation Business Overview
9.3.6 Invitae Corporation Recent Developments
9.4 3billion
9.4.1 3billion Basic Information
9.4.2 3billion Rare Disease Genetic Testing Product Overview
9.4.3 3billion Rare Disease Genetic Testing Product Market Performance
9.4.4 3billion Business Overview
9.4.5 3billion Recent Developments
9.5 Arup Laboratories
9.5.1 Arup Laboratories Basic Information
9.5.2 Arup Laboratories Rare Disease Genetic Testing Product Overview
9.5.3 Arup Laboratories Rare Disease Genetic Testing Product Market Performance
9.5.4 Arup Laboratories Business Overview
9.5.5 Arup Laboratories Recent Developments
9.6 Eurofins Scientific
9.6.1 Eurofins Scientific Basic Information
9.6.2 Eurofins Scientific Rare Disease Genetic Testing Product Overview
9.6.3 Eurofins Scientific Rare Disease Genetic Testing Product Market Performance
9.6.4 Eurofins Scientific Business Overview
9.6.5 Eurofins Scientific Recent Developments
9.7 Strand Life Sciences
9.7.1 Strand Life Sciences Basic Information
9.7.2 Strand Life Sciences Rare Disease Genetic Testing Product Overview
9.7.3 Strand Life Sciences Rare Disease Genetic Testing Product Market Performance
9.7.4 Strand Life Sciences Business Overview
9.7.5 Strand Life Sciences Recent Developments
9.8 Ambry Genetics
9.8.1 Ambry Genetics Basic Information
9.8.2 Ambry Genetics Rare Disease Genetic Testing Product Overview
9.8.3 Ambry Genetics Rare Disease Genetic Testing Product Market Performance
9.8.4 Ambry Genetics Business Overview
9.8.5 Ambry Genetics Recent Developments
9.9 Perkin Elmer
9.9.1 Perkin Elmer Basic Information
9.9.2 Perkin Elmer Rare Disease Genetic Testing Product Overview
9.9.3 Perkin Elmer Rare Disease Genetic Testing Product Market Performance
9.9.4 Perkin Elmer Business Overview
9.9.5 Perkin Elmer Recent Developments
9.10 Macrogen
9.10.1 Macrogen Basic Information
9.10.2 Macrogen Rare Disease Genetic Testing Product Overview
9.10.3 Macrogen Rare Disease Genetic Testing Product Market Performance
9.10.4 Macrogen Business Overview
9.10.5 Macrogen Recent Developments
9.11 Baylor Genetics
9.11.1 Baylor Genetics Basic Information
9.11.2 Baylor Genetics Rare Disease Genetic Testing Product Overview
9.11.3 Baylor Genetics Rare Disease Genetic Testing Product Market Performance
9.11.4 Baylor Genetics Business Overview
9.11.5 Baylor Genetics Recent Developments
9.12 Color Genomics
9.12.1 Color Genomics Basic Information
9.12.2 Color Genomics Rare Disease Genetic Testing Product Overview
9.12.3 Color Genomics Rare Disease Genetic Testing Product Market Performance
9.12.4 Color Genomics Business Overview
9.12.5 Color Genomics Recent Developments
9.13 Preventiongenetics
9.13.1 Preventiongenetics Basic Information
9.13.2 Preventiongenetics Rare Disease Genetic Testing Product Overview
9.13.3 Preventiongenetics Rare Disease Genetic Testing Product Market Performance
9.13.4 Preventiongenetics Business Overview
9.13.5 Preventiongenetics Recent Developments
9.14 Progenity
9.14.1 Progenity Basic Information
9.14.2 Progenity Rare Disease Genetic Testing Product Overview
9.14.3 Progenity Rare Disease Genetic Testing Product Market Performance
9.14.4 Progenity Business Overview
9.14.5 Progenity Recent Developments
9.15 Coopersurgical
9.15.1 Coopersurgical Basic Information
9.15.2 Coopersurgical Rare Disease Genetic Testing Product Overview
9.15.3 Coopersurgical Rare Disease Genetic Testing Product Market Performance
9.15.4 Coopersurgical Business Overview
9.15.5 Coopersurgical Recent Developments
9.16 Fulgent Genetics
9.16.1 Fulgent Genetics Basic Information
9.16.2 Fulgent Genetics Rare Disease Genetic Testing Product Overview
9.16.3 Fulgent Genetics Rare Disease Genetic Testing Product Market Performance
9.16.4 Fulgent Genetics Business Overview
9.16.5 Fulgent Genetics Recent Developments
9.17 Myriad Genetics
9.17.1 Myriad Genetics Basic Information
9.17.2 Myriad Genetics Rare Disease Genetic Testing Product Overview
9.17.3 Myriad Genetics Rare Disease Genetic Testing Product Market Performance
9.17.4 Myriad Genetics Business Overview
9.17.5 Myriad Genetics Recent Developments
9.18 LabCorp
9.18.1 LabCorp Basic Information
9.18.2 LabCorp Rare Disease Genetic Testing Product Overview
9.18.3 LabCorp Rare Disease Genetic Testing Product Market Performance
9.18.4 LabCorp Business Overview
9.18.5 LabCorp Recent Developments
9.19 Opko Health
9.19.1 Opko Health Basic Information
9.19.2 Opko Health Rare Disease Genetic Testing Product Overview
9.19.3 Opko Health Rare Disease Genetic Testing Product Market Performance
9.19.4 Opko Health Business Overview
9.19.5 Opko Health Recent Developments
10 RARE DISEASE GENETIC TESTING MARKET FORECAST BY REGION
10.1 Global Rare Disease Genetic Testing Market Size Forecast
10.2 Global Rare Disease Genetic Testing Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Rare Disease Genetic Testing Market Size Forecast by Country
10.2.3 Asia Pacific Rare Disease Genetic Testing Market Size Forecast by Region
10.2.4 South America Rare Disease Genetic Testing Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Sales of Rare Disease Genetic Testing by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
11.1 Global Rare Disease Genetic Testing Market Forecast by Type (2026-2033)
11.2 Global Rare Disease Genetic Testing Market Forecast by Application (2026-2033)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Rare Disease Genetic Testing
1.2 Key Market Segments
1.2.1 Rare Disease Genetic Testing Segment by Type
1.2.2 Rare Disease Genetic Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 RARE DISEASE GENETIC TESTING MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 RARE DISEASE GENETIC TESTING MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Rare Disease Genetic Testing Product Life Cycle
3.3 Global Rare Disease Genetic Testing Revenue Market Share by Company (2020-2025)
3.4 Rare Disease Genetic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Rare Disease Genetic Testing Company Headquarters, Area Served, Product Type
3.6 Rare Disease Genetic Testing Market Competitive Situation and Trends
3.6.1 Rare Disease Genetic Testing Market Concentration Rate
3.6.2 Global 5 and 10 Largest Rare Disease Genetic Testing Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 RARE DISEASE GENETIC TESTING VALUE CHAIN ANALYSIS
4.1 Rare Disease Genetic Testing Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF RARE DISEASE GENETIC TESTING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Rare Disease Genetic Testing Market Porter's Five Forces Analysis
6 RARE DISEASE GENETIC TESTING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Rare Disease Genetic Testing Market Size Market Share by Type (2020-2025)
6.3 Global Rare Disease Genetic Testing Market Size Growth Rate by Type (2021-2025)
7 RARE DISEASE GENETIC TESTING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Rare Disease Genetic Testing Market Size (M USD) by Application (2020-2025)
7.3 Global Rare Disease Genetic Testing Sales Growth Rate by Application (2020-2025)
8 RARE DISEASE GENETIC TESTING MARKET SEGMENTATION BY REGION
8.1 Global Rare Disease Genetic Testing Market Size by Region
8.1.1 Global Rare Disease Genetic Testing Market Size by Region
8.1.2 Global Rare Disease Genetic Testing Market Size Market Share by Region
8.2 North America
8.2.1 North America Rare Disease Genetic Testing Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Rare Disease Genetic Testing Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Spain
8.4 Asia Pacific
8.4.1 Asia Pacific Rare Disease Genetic Testing Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Rare Disease Genetic Testing Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Rare Disease Genetic Testing Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Quest Diagnostics
9.1.1 Quest Diagnostics Basic Information
9.1.2 Quest Diagnostics Rare Disease Genetic Testing Product Overview
9.1.3 Quest Diagnostics Rare Disease Genetic Testing Product Market Performance
9.1.4 Quest Diagnostics SWOT Analysis
9.1.5 Quest Diagnostics Business Overview
9.1.6 Quest Diagnostics Recent Developments
9.2 Centogene
9.2.1 Centogene Basic Information
9.2.2 Centogene Rare Disease Genetic Testing Product Overview
9.2.3 Centogene Rare Disease Genetic Testing Product Market Performance
9.2.4 Centogene SWOT Analysis
9.2.5 Centogene Business Overview
9.2.6 Centogene Recent Developments
9.3 Invitae Corporation
9.3.1 Invitae Corporation Basic Information
9.3.2 Invitae Corporation Rare Disease Genetic Testing Product Overview
9.3.3 Invitae Corporation Rare Disease Genetic Testing Product Market Performance
9.3.4 Invitae Corporation SWOT Analysis
9.3.5 Invitae Corporation Business Overview
9.3.6 Invitae Corporation Recent Developments
9.4 3billion
9.4.1 3billion Basic Information
9.4.2 3billion Rare Disease Genetic Testing Product Overview
9.4.3 3billion Rare Disease Genetic Testing Product Market Performance
9.4.4 3billion Business Overview
9.4.5 3billion Recent Developments
9.5 Arup Laboratories
9.5.1 Arup Laboratories Basic Information
9.5.2 Arup Laboratories Rare Disease Genetic Testing Product Overview
9.5.3 Arup Laboratories Rare Disease Genetic Testing Product Market Performance
9.5.4 Arup Laboratories Business Overview
9.5.5 Arup Laboratories Recent Developments
9.6 Eurofins Scientific
9.6.1 Eurofins Scientific Basic Information
9.6.2 Eurofins Scientific Rare Disease Genetic Testing Product Overview
9.6.3 Eurofins Scientific Rare Disease Genetic Testing Product Market Performance
9.6.4 Eurofins Scientific Business Overview
9.6.5 Eurofins Scientific Recent Developments
9.7 Strand Life Sciences
9.7.1 Strand Life Sciences Basic Information
9.7.2 Strand Life Sciences Rare Disease Genetic Testing Product Overview
9.7.3 Strand Life Sciences Rare Disease Genetic Testing Product Market Performance
9.7.4 Strand Life Sciences Business Overview
9.7.5 Strand Life Sciences Recent Developments
9.8 Ambry Genetics
9.8.1 Ambry Genetics Basic Information
9.8.2 Ambry Genetics Rare Disease Genetic Testing Product Overview
9.8.3 Ambry Genetics Rare Disease Genetic Testing Product Market Performance
9.8.4 Ambry Genetics Business Overview
9.8.5 Ambry Genetics Recent Developments
9.9 Perkin Elmer
9.9.1 Perkin Elmer Basic Information
9.9.2 Perkin Elmer Rare Disease Genetic Testing Product Overview
9.9.3 Perkin Elmer Rare Disease Genetic Testing Product Market Performance
9.9.4 Perkin Elmer Business Overview
9.9.5 Perkin Elmer Recent Developments
9.10 Macrogen
9.10.1 Macrogen Basic Information
9.10.2 Macrogen Rare Disease Genetic Testing Product Overview
9.10.3 Macrogen Rare Disease Genetic Testing Product Market Performance
9.10.4 Macrogen Business Overview
9.10.5 Macrogen Recent Developments
9.11 Baylor Genetics
9.11.1 Baylor Genetics Basic Information
9.11.2 Baylor Genetics Rare Disease Genetic Testing Product Overview
9.11.3 Baylor Genetics Rare Disease Genetic Testing Product Market Performance
9.11.4 Baylor Genetics Business Overview
9.11.5 Baylor Genetics Recent Developments
9.12 Color Genomics
9.12.1 Color Genomics Basic Information
9.12.2 Color Genomics Rare Disease Genetic Testing Product Overview
9.12.3 Color Genomics Rare Disease Genetic Testing Product Market Performance
9.12.4 Color Genomics Business Overview
9.12.5 Color Genomics Recent Developments
9.13 Preventiongenetics
9.13.1 Preventiongenetics Basic Information
9.13.2 Preventiongenetics Rare Disease Genetic Testing Product Overview
9.13.3 Preventiongenetics Rare Disease Genetic Testing Product Market Performance
9.13.4 Preventiongenetics Business Overview
9.13.5 Preventiongenetics Recent Developments
9.14 Progenity
9.14.1 Progenity Basic Information
9.14.2 Progenity Rare Disease Genetic Testing Product Overview
9.14.3 Progenity Rare Disease Genetic Testing Product Market Performance
9.14.4 Progenity Business Overview
9.14.5 Progenity Recent Developments
9.15 Coopersurgical
9.15.1 Coopersurgical Basic Information
9.15.2 Coopersurgical Rare Disease Genetic Testing Product Overview
9.15.3 Coopersurgical Rare Disease Genetic Testing Product Market Performance
9.15.4 Coopersurgical Business Overview
9.15.5 Coopersurgical Recent Developments
9.16 Fulgent Genetics
9.16.1 Fulgent Genetics Basic Information
9.16.2 Fulgent Genetics Rare Disease Genetic Testing Product Overview
9.16.3 Fulgent Genetics Rare Disease Genetic Testing Product Market Performance
9.16.4 Fulgent Genetics Business Overview
9.16.5 Fulgent Genetics Recent Developments
9.17 Myriad Genetics
9.17.1 Myriad Genetics Basic Information
9.17.2 Myriad Genetics Rare Disease Genetic Testing Product Overview
9.17.3 Myriad Genetics Rare Disease Genetic Testing Product Market Performance
9.17.4 Myriad Genetics Business Overview
9.17.5 Myriad Genetics Recent Developments
9.18 LabCorp
9.18.1 LabCorp Basic Information
9.18.2 LabCorp Rare Disease Genetic Testing Product Overview
9.18.3 LabCorp Rare Disease Genetic Testing Product Market Performance
9.18.4 LabCorp Business Overview
9.18.5 LabCorp Recent Developments
9.19 Opko Health
9.19.1 Opko Health Basic Information
9.19.2 Opko Health Rare Disease Genetic Testing Product Overview
9.19.3 Opko Health Rare Disease Genetic Testing Product Market Performance
9.19.4 Opko Health Business Overview
9.19.5 Opko Health Recent Developments
10 RARE DISEASE GENETIC TESTING MARKET FORECAST BY REGION
10.1 Global Rare Disease Genetic Testing Market Size Forecast
10.2 Global Rare Disease Genetic Testing Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Rare Disease Genetic Testing Market Size Forecast by Country
10.2.3 Asia Pacific Rare Disease Genetic Testing Market Size Forecast by Region
10.2.4 South America Rare Disease Genetic Testing Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Sales of Rare Disease Genetic Testing by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
11.1 Global Rare Disease Genetic Testing Market Forecast by Type (2026-2033)
11.2 Global Rare Disease Genetic Testing Market Forecast by Application (2026-2033)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Rare Disease Genetic Testing Market Size Comparison by Region (M USD)
Table 5. Global Rare Disease Genetic Testing Revenue (M USD) by Company (2020-2025)
Table 6. Global Rare Disease Genetic Testing Revenue Share by Company (2020-2025)
Table 7. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rare Disease Genetic Testing as of 2024)
Table 8. Rare Disease Genetic Testing Company Headquarters and Area Served
Table 9. Company Rare Disease Genetic Testing Product Type
Table 10. Global Rare Disease Genetic Testing Company Market Concentration Ratio (CR5 and HHI)
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. Midstream Market Analysis
Table 13. Downstream Customer Analysis
Table 14. Key Development Trends
Table 15. Driving Factors
Table 16. Rare Disease Genetic Testing Market Challenges
Table 17. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 18. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 19. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 20. Global Rare Disease Genetic Testing Market Size by Type (M USD)
Table 21. Global Rare Disease Genetic Testing Market Size (M USD) by Type (2020-2025)
Table 22. Global Rare Disease Genetic Testing Market Size Share by Type (2020-2025)
Table 23. Global Rare Disease Genetic Testing Market Size Growth Rate by Type (2021-2025)
Table 24. Global Rare Disease Genetic Testing Market Size by Application
Table 25. Global Rare Disease Genetic Testing Market Size by Application (2020-2025) & (M USD)
Table 26. Global Rare Disease Genetic Testing Market Share by Application (2020-2025)
Table 27. Global Rare Disease Genetic Testing Sales Growth Rate by Application (2020-2025)
Table 28. Global Rare Disease Genetic Testing Market Size by Region (2020-2025) & (M USD)
Table 29. Global Rare Disease Genetic Testing Market Size Market Share by Region (2020-2025)
Table 30. North America Rare Disease Genetic Testing Market Size by Country (2020-2025) & (M USD)
Table 31. Europe Rare Disease Genetic Testing Market Size by Country (2020-2025) & (M USD)
Table 32. Asia Pacific Rare Disease Genetic Testing Market Size by Region (2020-2025) & (M USD)
Table 33. South America Rare Disease Genetic Testing Market Size by Country (2020-2025) & (M USD)
Table 34. Middle East and Africa Rare Disease Genetic Testing Market Size by Region (2020-2025) & (M USD)
Table 35. Quest Diagnostics Basic Information
Table 36. Quest Diagnostics Rare Disease Genetic Testing Product Overview
Table 37. Quest Diagnostics Rare Disease Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 38. Quest Diagnostics SWOT Analysis
Table 39. Quest Diagnostics Business Overview
Table 40. Quest Diagnostics Recent Developments
Table 41. Centogene Basic Information
Table 42. Centogene Rare Disease Genetic Testing Product Overview
Table 43. Centogene Rare Disease Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 44. Centogene SWOT Analysis
Table 45. Centogene Business Overview
Table 46. Centogene Recent Developments
Table 47. Invitae Corporation Basic Information
Table 48. Invitae Corporation Rare Disease Genetic Testing Product Overview
Table 49. Invitae Corporation Rare Disease Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 50. Invitae Corporation SWOT Analysis
Table 51. Invitae Corporation Business Overview
Table 52. Invitae Corporation Recent Developments
Table 53. 3billion Basic Information
Table 54. 3billion Rare Disease Genetic Testing Product Overview
Table 55. 3billion Rare Disease Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 56. 3billion Business Overview
Table 57. 3billion Recent Developments
Table 58. Arup Laboratories Basic Information
Table 59. Arup Laboratories Rare Disease Genetic Testing Product Overview
Table 60. Arup Laboratories Rare Disease Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 61. Arup Laboratories Business Overview
Table 62. Arup Laboratories Recent Developments
Table 63. Eurofins Scientific Basic Information
Table 64. Eurofins Scientific Rare Disease Genetic Testing Product Overview
Table 65. Eurofins Scientific Rare Disease Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 66. Eurofins Scientific Business Overview
Table 67. Eurofins Scientific Recent Developments
Table 68. Strand Life Sciences Basic Information
Table 69. Strand Life Sciences Rare Disease Genetic Testing Product Overview
Table 70. Strand Life Sciences Rare Disease Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 71. Strand Life Sciences Business Overview
Table 72. Strand Life Sciences Recent Developments
Table 73. Ambry Genetics Basic Information
Table 74. Ambry Genetics Rare Disease Genetic Testing Product Overview
Table 75. Ambry Genetics Rare Disease Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 76. Ambry Genetics Business Overview
Table 77. Ambry Genetics Recent Developments
Table 78. Perkin Elmer Basic Information
Table 79. Perkin Elmer Rare Disease Genetic Testing Product Overview
Table 80. Perkin Elmer Rare Disease Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 81. Perkin Elmer Business Overview
Table 82. Perkin Elmer Recent Developments
Table 83. Macrogen Basic Information
Table 84. Macrogen Rare Disease Genetic Testing Product Overview
Table 85. Macrogen Rare Disease Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 86. Macrogen Business Overview
Table 87. Macrogen Recent Developments
Table 88. Baylor Genetics Basic Information
Table 89. Baylor Genetics Rare Disease Genetic Testing Product Overview
Table 90. Baylor Genetics Rare Disease Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 91. Baylor Genetics Business Overview
Table 92. Baylor Genetics Recent Developments
Table 93. Color Genomics Basic Information
Table 94. Color Genomics Rare Disease Genetic Testing Product Overview
Table 95. Color Genomics Rare Disease Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 96. Color Genomics Business Overview
Table 97. Color Genomics Recent Developments
Table 98. Preventiongenetics Basic Information
Table 99. Preventiongenetics Rare Disease Genetic Testing Product Overview
Table 100. Preventiongenetics Rare Disease Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 101. Preventiongenetics Business Overview
Table 102. Preventiongenetics Recent Developments
Table 103. Progenity Basic Information
Table 104. Progenity Rare Disease Genetic Testing Product Overview
Table 105. Progenity Rare Disease Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 106. Progenity Business Overview
Table 107. Progenity Recent Developments
Table 108. Coopersurgical Basic Information
Table 109. Coopersurgical Rare Disease Genetic Testing Product Overview
Table 110. Coopersurgical Rare Disease Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 111. Coopersurgical Business Overview
Table 112. Coopersurgical Recent Developments
Table 113. Fulgent Genetics Basic Information
Table 114. Fulgent Genetics Rare Disease Genetic Testing Product Overview
Table 115. Fulgent Genetics Rare Disease Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 116. Fulgent Genetics Business Overview
Table 117. Fulgent Genetics Recent Developments
Table 118. Myriad Genetics Basic Information
Table 119. Myriad Genetics Rare Disease Genetic Testing Product Overview
Table 120. Myriad Genetics Rare Disease Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 121. Myriad Genetics Business Overview
Table 122. Myriad Genetics Recent Developments
Table 123. LabCorp Basic Information
Table 124. LabCorp Rare Disease Genetic Testing Product Overview
Table 125. LabCorp Rare Disease Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 126. LabCorp Business Overview
Table 127. LabCorp Recent Developments
Table 128. Opko Health Basic Information
Table 129. Opko Health Rare Disease Genetic Testing Product Overview
Table 130. Opko Health Rare Disease Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 131. Opko Health Business Overview
Table 132. Opko Health Recent Developments
Table 133. Global Rare Disease Genetic Testing Market Size Forecast by Region (2026-2033) & (M USD)
Table 134. North America Rare Disease Genetic Testing Market Size Forecast by Country (2026-2033) & (M USD)
Table 135. Europe Rare Disease Genetic Testing Market Size Forecast by Country (2026-2033) & (M USD)
Table 136. Asia Pacific Rare Disease Genetic Testing Market Size Forecast by Region (2026-2033) & (M USD)
Table 137. South America Rare Disease Genetic Testing Market Size Forecast by Country (2026-2033) & (M USD)
Table 138. Middle East and Africa Rare Disease Genetic Testing Market Size Forecast by Country (2026-2033) & (M USD)
Table 139. Global Rare Disease Genetic Testing Market Size Forecast by Type (2026-2033) & (M USD)
Table 140. Global Rare Disease Genetic Testing Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Rare Disease Genetic Testing Market Size Comparison by Region (M USD)
Table 5. Global Rare Disease Genetic Testing Revenue (M USD) by Company (2020-2025)
Table 6. Global Rare Disease Genetic Testing Revenue Share by Company (2020-2025)
Table 7. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rare Disease Genetic Testing as of 2024)
Table 8. Rare Disease Genetic Testing Company Headquarters and Area Served
Table 9. Company Rare Disease Genetic Testing Product Type
Table 10. Global Rare Disease Genetic Testing Company Market Concentration Ratio (CR5 and HHI)
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. Midstream Market Analysis
Table 13. Downstream Customer Analysis
Table 14. Key Development Trends
Table 15. Driving Factors
Table 16. Rare Disease Genetic Testing Market Challenges
Table 17. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 18. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 19. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 20. Global Rare Disease Genetic Testing Market Size by Type (M USD)
Table 21. Global Rare Disease Genetic Testing Market Size (M USD) by Type (2020-2025)
Table 22. Global Rare Disease Genetic Testing Market Size Share by Type (2020-2025)
Table 23. Global Rare Disease Genetic Testing Market Size Growth Rate by Type (2021-2025)
Table 24. Global Rare Disease Genetic Testing Market Size by Application
Table 25. Global Rare Disease Genetic Testing Market Size by Application (2020-2025) & (M USD)
Table 26. Global Rare Disease Genetic Testing Market Share by Application (2020-2025)
Table 27. Global Rare Disease Genetic Testing Sales Growth Rate by Application (2020-2025)
Table 28. Global Rare Disease Genetic Testing Market Size by Region (2020-2025) & (M USD)
Table 29. Global Rare Disease Genetic Testing Market Size Market Share by Region (2020-2025)
Table 30. North America Rare Disease Genetic Testing Market Size by Country (2020-2025) & (M USD)
Table 31. Europe Rare Disease Genetic Testing Market Size by Country (2020-2025) & (M USD)
Table 32. Asia Pacific Rare Disease Genetic Testing Market Size by Region (2020-2025) & (M USD)
Table 33. South America Rare Disease Genetic Testing Market Size by Country (2020-2025) & (M USD)
Table 34. Middle East and Africa Rare Disease Genetic Testing Market Size by Region (2020-2025) & (M USD)
Table 35. Quest Diagnostics Basic Information
Table 36. Quest Diagnostics Rare Disease Genetic Testing Product Overview
Table 37. Quest Diagnostics Rare Disease Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 38. Quest Diagnostics SWOT Analysis
Table 39. Quest Diagnostics Business Overview
Table 40. Quest Diagnostics Recent Developments
Table 41. Centogene Basic Information
Table 42. Centogene Rare Disease Genetic Testing Product Overview
Table 43. Centogene Rare Disease Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 44. Centogene SWOT Analysis
Table 45. Centogene Business Overview
Table 46. Centogene Recent Developments
Table 47. Invitae Corporation Basic Information
Table 48. Invitae Corporation Rare Disease Genetic Testing Product Overview
Table 49. Invitae Corporation Rare Disease Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 50. Invitae Corporation SWOT Analysis
Table 51. Invitae Corporation Business Overview
Table 52. Invitae Corporation Recent Developments
Table 53. 3billion Basic Information
Table 54. 3billion Rare Disease Genetic Testing Product Overview
Table 55. 3billion Rare Disease Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 56. 3billion Business Overview
Table 57. 3billion Recent Developments
Table 58. Arup Laboratories Basic Information
Table 59. Arup Laboratories Rare Disease Genetic Testing Product Overview
Table 60. Arup Laboratories Rare Disease Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 61. Arup Laboratories Business Overview
Table 62. Arup Laboratories Recent Developments
Table 63. Eurofins Scientific Basic Information
Table 64. Eurofins Scientific Rare Disease Genetic Testing Product Overview
Table 65. Eurofins Scientific Rare Disease Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 66. Eurofins Scientific Business Overview
Table 67. Eurofins Scientific Recent Developments
Table 68. Strand Life Sciences Basic Information
Table 69. Strand Life Sciences Rare Disease Genetic Testing Product Overview
Table 70. Strand Life Sciences Rare Disease Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 71. Strand Life Sciences Business Overview
Table 72. Strand Life Sciences Recent Developments
Table 73. Ambry Genetics Basic Information
Table 74. Ambry Genetics Rare Disease Genetic Testing Product Overview
Table 75. Ambry Genetics Rare Disease Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 76. Ambry Genetics Business Overview
Table 77. Ambry Genetics Recent Developments
Table 78. Perkin Elmer Basic Information
Table 79. Perkin Elmer Rare Disease Genetic Testing Product Overview
Table 80. Perkin Elmer Rare Disease Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 81. Perkin Elmer Business Overview
Table 82. Perkin Elmer Recent Developments
Table 83. Macrogen Basic Information
Table 84. Macrogen Rare Disease Genetic Testing Product Overview
Table 85. Macrogen Rare Disease Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 86. Macrogen Business Overview
Table 87. Macrogen Recent Developments
Table 88. Baylor Genetics Basic Information
Table 89. Baylor Genetics Rare Disease Genetic Testing Product Overview
Table 90. Baylor Genetics Rare Disease Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 91. Baylor Genetics Business Overview
Table 92. Baylor Genetics Recent Developments
Table 93. Color Genomics Basic Information
Table 94. Color Genomics Rare Disease Genetic Testing Product Overview
Table 95. Color Genomics Rare Disease Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 96. Color Genomics Business Overview
Table 97. Color Genomics Recent Developments
Table 98. Preventiongenetics Basic Information
Table 99. Preventiongenetics Rare Disease Genetic Testing Product Overview
Table 100. Preventiongenetics Rare Disease Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 101. Preventiongenetics Business Overview
Table 102. Preventiongenetics Recent Developments
Table 103. Progenity Basic Information
Table 104. Progenity Rare Disease Genetic Testing Product Overview
Table 105. Progenity Rare Disease Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 106. Progenity Business Overview
Table 107. Progenity Recent Developments
Table 108. Coopersurgical Basic Information
Table 109. Coopersurgical Rare Disease Genetic Testing Product Overview
Table 110. Coopersurgical Rare Disease Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 111. Coopersurgical Business Overview
Table 112. Coopersurgical Recent Developments
Table 113. Fulgent Genetics Basic Information
Table 114. Fulgent Genetics Rare Disease Genetic Testing Product Overview
Table 115. Fulgent Genetics Rare Disease Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 116. Fulgent Genetics Business Overview
Table 117. Fulgent Genetics Recent Developments
Table 118. Myriad Genetics Basic Information
Table 119. Myriad Genetics Rare Disease Genetic Testing Product Overview
Table 120. Myriad Genetics Rare Disease Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 121. Myriad Genetics Business Overview
Table 122. Myriad Genetics Recent Developments
Table 123. LabCorp Basic Information
Table 124. LabCorp Rare Disease Genetic Testing Product Overview
Table 125. LabCorp Rare Disease Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 126. LabCorp Business Overview
Table 127. LabCorp Recent Developments
Table 128. Opko Health Basic Information
Table 129. Opko Health Rare Disease Genetic Testing Product Overview
Table 130. Opko Health Rare Disease Genetic Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 131. Opko Health Business Overview
Table 132. Opko Health Recent Developments
Table 133. Global Rare Disease Genetic Testing Market Size Forecast by Region (2026-2033) & (M USD)
Table 134. North America Rare Disease Genetic Testing Market Size Forecast by Country (2026-2033) & (M USD)
Table 135. Europe Rare Disease Genetic Testing Market Size Forecast by Country (2026-2033) & (M USD)
Table 136. Asia Pacific Rare Disease Genetic Testing Market Size Forecast by Region (2026-2033) & (M USD)
Table 137. South America Rare Disease Genetic Testing Market Size Forecast by Country (2026-2033) & (M USD)
Table 138. Middle East and Africa Rare Disease Genetic Testing Market Size Forecast by Country (2026-2033) & (M USD)
Table 139. Global Rare Disease Genetic Testing Market Size Forecast by Type (2026-2033) & (M USD)
Table 140. Global Rare Disease Genetic Testing Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Industry Chain of Rare Disease Genetic Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Rare Disease Genetic Testing Market Size (M USD), 2024-2033
Figure 5. Global Rare Disease Genetic Testing Market Size (M USD) (2020-2033)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Rare Disease Genetic Testing Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Rare Disease Genetic Testing Product Life Cycle
Figure 12. Global Rare Disease Genetic Testing Revenue Share by Company in 2024
Figure 13. Rare Disease Genetic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 14. The Global 5 and 10 Largest Players: Market Share by Rare Disease Genetic Testing Revenue in 2024
Figure 15. Value Chain Map of Rare Disease Genetic Testing
Figure 16. Global Rare Disease Genetic Testing Market PEST Analysis
Figure 17. Global Rare Disease Genetic Testing Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global Rare Disease Genetic Testing Market Share by Type
Figure 20. Market Size Share of Rare Disease Genetic Testing by Type (2020-2025)
Figure 21. Market Size Share of Rare Disease Genetic Testing by Type in 2024
Figure 22. Global Rare Disease Genetic Testing Market Size Growth Rate by Type (2021-2025)
Figure 23. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 24. Global Rare Disease Genetic Testing Market Share by Application
Figure 25. Global Rare Disease Genetic Testing Market Share by Application (2020-2025)
Figure 26. Global Rare Disease Genetic Testing Market Share by Application in 2024
Figure 27. Global Rare Disease Genetic Testing Sales Growth Rate by Application (2020-2025)
Figure 28. Global Rare Disease Genetic Testing Market Size Market Share by Region (2020-2025)
Figure 29. North America Rare Disease Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 30. North America Rare Disease Genetic Testing Market Size Market Share by Country in 2024
Figure 31. U.S. Rare Disease Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 32. Canada Rare Disease Genetic Testing Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Mexico Rare Disease Genetic Testing Market Size (M USD) and Growth Rate (2020-2025)
Figure 34. Europe Rare Disease Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 35. Europe Rare Disease Genetic Testing Market Share by Country in 2024
Figure 36. Germany Rare Disease Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. France Rare Disease Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. U.K. Rare Disease Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Italy Rare Disease Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Spain Rare Disease Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 41. Asia Pacific Rare Disease Genetic Testing Market Size and Growth Rate (M USD)
Figure 42. Asia Pacific Rare Disease Genetic Testing Market Size Market Share by Region in 2024
Figure 43. China Rare Disease Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. Japan Rare Disease Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. South Korea Rare Disease Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. India Rare Disease Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Southeast Asia Rare Disease Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 48. South America Rare Disease Genetic Testing Market Size and Growth Rate (M USD)
Figure 49. South America Rare Disease Genetic Testing Market Size Market Share by Country in 2024
Figure 50. Brazil Rare Disease Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Argentina Rare Disease Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Columbia Rare Disease Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 53. Middle East and Africa Rare Disease Genetic Testing Market Size and Growth Rate (M USD)
Figure 54. Middle East and Africa Rare Disease Genetic Testing Market Size Market Share by Region in 2024
Figure 55. Saudi Arabia Rare Disease Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. UAE Rare Disease Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Egypt Rare Disease Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. Nigeria Rare Disease Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. South Africa Rare Disease Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Global Rare Disease Genetic Testing Market Size Forecast (2020-2033) & (M USD)
Figure 61. Global Rare Disease Genetic Testing Market Share Forecast by Type (2026-2033)
Figure 62. Global Rare Disease Genetic Testing Market Share Forecast by Application (2026-2033)
Figure 1. Industry Chain of Rare Disease Genetic Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Rare Disease Genetic Testing Market Size (M USD), 2024-2033
Figure 5. Global Rare Disease Genetic Testing Market Size (M USD) (2020-2033)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Rare Disease Genetic Testing Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Rare Disease Genetic Testing Product Life Cycle
Figure 12. Global Rare Disease Genetic Testing Revenue Share by Company in 2024
Figure 13. Rare Disease Genetic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 14. The Global 5 and 10 Largest Players: Market Share by Rare Disease Genetic Testing Revenue in 2024
Figure 15. Value Chain Map of Rare Disease Genetic Testing
Figure 16. Global Rare Disease Genetic Testing Market PEST Analysis
Figure 17. Global Rare Disease Genetic Testing Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global Rare Disease Genetic Testing Market Share by Type
Figure 20. Market Size Share of Rare Disease Genetic Testing by Type (2020-2025)
Figure 21. Market Size Share of Rare Disease Genetic Testing by Type in 2024
Figure 22. Global Rare Disease Genetic Testing Market Size Growth Rate by Type (2021-2025)
Figure 23. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 24. Global Rare Disease Genetic Testing Market Share by Application
Figure 25. Global Rare Disease Genetic Testing Market Share by Application (2020-2025)
Figure 26. Global Rare Disease Genetic Testing Market Share by Application in 2024
Figure 27. Global Rare Disease Genetic Testing Sales Growth Rate by Application (2020-2025)
Figure 28. Global Rare Disease Genetic Testing Market Size Market Share by Region (2020-2025)
Figure 29. North America Rare Disease Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 30. North America Rare Disease Genetic Testing Market Size Market Share by Country in 2024
Figure 31. U.S. Rare Disease Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 32. Canada Rare Disease Genetic Testing Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Mexico Rare Disease Genetic Testing Market Size (M USD) and Growth Rate (2020-2025)
Figure 34. Europe Rare Disease Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 35. Europe Rare Disease Genetic Testing Market Share by Country in 2024
Figure 36. Germany Rare Disease Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. France Rare Disease Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. U.K. Rare Disease Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Italy Rare Disease Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Spain Rare Disease Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 41. Asia Pacific Rare Disease Genetic Testing Market Size and Growth Rate (M USD)
Figure 42. Asia Pacific Rare Disease Genetic Testing Market Size Market Share by Region in 2024
Figure 43. China Rare Disease Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. Japan Rare Disease Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. South Korea Rare Disease Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. India Rare Disease Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Southeast Asia Rare Disease Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 48. South America Rare Disease Genetic Testing Market Size and Growth Rate (M USD)
Figure 49. South America Rare Disease Genetic Testing Market Size Market Share by Country in 2024
Figure 50. Brazil Rare Disease Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Argentina Rare Disease Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Columbia Rare Disease Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 53. Middle East and Africa Rare Disease Genetic Testing Market Size and Growth Rate (M USD)
Figure 54. Middle East and Africa Rare Disease Genetic Testing Market Size Market Share by Region in 2024
Figure 55. Saudi Arabia Rare Disease Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. UAE Rare Disease Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Egypt Rare Disease Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. Nigeria Rare Disease Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. South Africa Rare Disease Genetic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Global Rare Disease Genetic Testing Market Size Forecast (2020-2033) & (M USD)
Figure 61. Global Rare Disease Genetic Testing Market Share Forecast by Type (2026-2033)
Figure 62. Global Rare Disease Genetic Testing Market Share Forecast by Application (2026-2033)